Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Kedokteran Diponegoro
Fachrizal Arfani Prawiragara
Department of Orthopaedic and Traumatology, Faculty of Medicine, Universitas Pembangunan Nasional "Veteran" Jawa Timur, Surabaya, Indonesia, 60294
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
COMPARISON OF QUALITY OF LIFE (QOL) IN PATIENTS WITH METASTATIC BONE DISEASE (MBD) BEFORE AND AFTER BISPHOSPHONATE THERAPY BASED ON CALCIUM LEVELS Fachrizal Arfani Prawiragara; Hilmia Fahma; Debrina Kusuma Devi; Leonardo Tedjaprasadja
Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal) Vol 15, No 4 (2026): JURNAL KEDOKTERAN DIPONEGORO (DIPONEGORO MEDICAL JOURNAL)
Publisher : Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14710/dmj.v15i4.54076

Abstract

Background: Metastatic bone disease (MBD) is a frequent complication in advanced cancer, often resulting in pain, limited mobility, and reduced QoL. Bisphosphonates are effective in minimizing skeletal-related events by suppressing osteoclast activity. Objective: To assess the impact of bisphosphonate therapy on serum calcium levels and QoL in patients with metastatic bone disease. Methods: A retrospective cohort study was conducted involving 228 MBD patients treated at Dr. Soetomo General Hospital from 2015 to 2020. Surgical eligibility was determined using the Abdurrahman Score. Pre- and post-treatment data on serum calcium levels and Karnofsky Scores were collected and analyzed using paired t-tests. Results: In the surgical group, the mean Karnofsky Score improved from 46.67 ± 12.69 to 77.67 ± 9.35 (p < 0.001), while serum calcium levels decreased from 10.1 ± 1.20 to 7.3 ± 1.01 (p < 0.001). In the non-surgical group, Karnofsky Scores increased from 36.67 ± 12.22 to 49.35 ± 13.15, and calcium levels declined from 10.2 ± 1.18 to 7.6 ± 1.33 (both p < 0.001). Conclusion: Bisphosphonate therapy significantly enhances QoL and reduces serum calcium levels in patients with metastatic bone disease. The combination of surgical management and bisphosphonate therapy yields superior functional outcomes compared to non-surgical treatment.
Co-Authors Debrina Kusuma Devi Hilmia Fahma Leonardo Tedjaprasadja